168 related articles for article (PubMed ID: 7954939)
1. Amino acids and peptides. XXIV. Preparation and antinociceptive effect of [D-Ala2,(N-Me)Phe4]enkephalin analog-poly(ethylene glycol) hybrids.
Maeda M; Kawasaki K; Takahashi M; Nakao K; Kaneto H
Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1859-63. PubMed ID: 7954939
[TBL] [Abstract][Full Text] [Related]
2. Amino acids and peptides. XXII. Preparation and antinociceptive effect of [D-Ala2]Leu-enkephalin-poly(ethylene glycol) hybrid.
Maeda M; Kawasaki K; Mayumi T; Takahashi M; Kaneto H
Biol Pharm Bull; 1994 Jun; 17(6):823-5. PubMed ID: 7951146
[TBL] [Abstract][Full Text] [Related]
3. Opioid activities of D-Arg2-substituted tetrapeptides.
Sato T; Sakurada S; Sakurada T; Furuta S; Chaki K; Kisara K; Sasaki Y; Suzuki K
J Pharmacol Exp Ther; 1987 Aug; 242(2):654-9. PubMed ID: 3612556
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive properties of two alkylating derivatives of morphinone: 14 beta-(thioglycolamido)-7,8-dihydromorphinone (TAMO) and 14 beta-(bromoacetamido)-7,8-dihydromorphinone (H2BAMO).
Jiang Q; Seyed-Mozaffari A; Archer S; Bidlack JM
J Pharmacol Exp Ther; 1992 Aug; 262(2):526-31. PubMed ID: 1380079
[TBL] [Abstract][Full Text] [Related]
5. Opioid agonist and antagonist antinociceptive properties of [D-Ala2,Leu5,Cys6]enkephalin: selective actions at the deltanoncomplexed site.
Qi JA; Bowen WD; Mosberg HI; Rothman RB; Porreca F
J Pharmacol Exp Ther; 1990 Nov; 255(2):636-41. PubMed ID: 2173752
[TBL] [Abstract][Full Text] [Related]
6. Influence of peptidase inhibitors on the apparent agonist potency of delta selective opioid peptides in vitro.
Kramer TH; Toth G; Haaseth RC; Matsunaga TO; Davis P; Hruby VJ; Burks TF
Life Sci; 1991; 48(9):881-6. PubMed ID: 1847736
[TBL] [Abstract][Full Text] [Related]
7. Amino acids and peptides. XIX. Preparation of enkephalin-poly(ethylene glycol) hybrid and evaluation of its analgesic activity.
Kawasaki K; Maeda M; Yamashiro Y; Mayumi T; Takahashi M; Kaneto H
Chem Pharm Bull (Tokyo); 1993 Nov; 41(11):2053-4. PubMed ID: 8293529
[TBL] [Abstract][Full Text] [Related]
8. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
9. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
10. Opioid modulation of basal intestinal fluid transport in the mouse: actions at central, but not intestinal, sites.
Jiang Q; Sheldon RJ; Porreca F
J Pharmacol Exp Ther; 1990 May; 253(2):784-90. PubMed ID: 2160010
[TBL] [Abstract][Full Text] [Related]
11. Conformational-energy studies of tetrapeptide opiates. Candidate active and inactive conformations.
Loew G; Hashimoto G; Williamson L; Burt S; Anderson W
Mol Pharmacol; 1982 Nov; 22(3):667-77. PubMed ID: 7155126
[TBL] [Abstract][Full Text] [Related]
12. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
Liederer BM; Borchardt RT
J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity profiles of cyclic and linear enkephalin pseudopeptide analogs.
Edwards JV; Spatola AF; Lemieux C; Schiller PW
Biochem Biophys Res Commun; 1986 Apr; 136(2):730-6. PubMed ID: 3010995
[TBL] [Abstract][Full Text] [Related]
14. Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.
Noble F; Smadja C; Roques BP
J Pharmacol Exp Ther; 1994 Dec; 271(3):1127-34. PubMed ID: 7996417
[TBL] [Abstract][Full Text] [Related]
15. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
16. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
[TBL] [Abstract][Full Text] [Related]
17. Synthetic studies on enkephalin analogs. II. Enhanced analgesic activity of H-Tyr-D-Ala-Gly-Phe-NHNH-CO-CH2CH3 following N-methylation of Tyr and Phe.
Shinagawa S; Fujino M; Ishii H; Kawai K
Chem Pharm Bull (Tokyo); 1981 Dec; 29(12):3639-45. PubMed ID: 7340951
[No Abstract] [Full Text] [Related]
18. Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors.
Kosterlitz HW; Lord JA; Paterson SJ; Waterfield AA
Br J Pharmacol; 1980 Feb; 68(2):333-42. PubMed ID: 6101980
[TBL] [Abstract][Full Text] [Related]
19. Effects of amino acid chirality and the chemical linker on the cell permeation characteristics of cyclic prodrugs of opioid peptides.
Liederer BM; Fuchs T; Vander Velde D; Siahaan TJ; Borchardt RT
J Med Chem; 2006 Feb; 49(4):1261-70. PubMed ID: 16480263
[TBL] [Abstract][Full Text] [Related]
20. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
